Tag: National Institutes of Health
Vaxxas to develop first room-temperature stable RSV vaccine with NIH license
Vaxxas, a clinical-stage biotechnology company known for its innovative high-density microarray patch (HD-MAP) vaccination platform, has secured a worldwide license from the United States National Institutes of Health (NIH) for a next-generation vaccine antigen aimed at combating Respiratory Syncytial Virus (RSV).Â
3D-printed skin technology offers hope for wound healing and hair restoration
A recent breakthrough in 3D bioprinting technology has paved the way for the creation of multi-layered living skin with the potential to regenerate hair follicles.
MIT researchers develop 3D-printed heart that functions like a real one
Engineers at the Massachusetts Institute of Technology have devised a method for 3D printing a soft and flexible replica of a patient's heart in the hopes of helping doctors tailor treatments to patients’ specific heart form and function.
Featured Article
Good Design Australia opens entries for 2026 awards
For more than six decades, Good Design Australia has celebrated the power of design to shape innovation, industry, and everyday life. Its flagship program, the Australian Good Design Awards, recognises projects that show how thoughtful design can enhance products, services, systems, and communities.
